PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-22.48%
Both yoy net incomes decline, with TSM at -10.53%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
No Data
No Data available this quarter, please select a different quarter.
-56.86%
Negative yoy deferred tax while TSM stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
7.04%
SBC growth of 7.04% while TSM is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
-240.00%
Both reduce yoy usage, with TSM at -126.94%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-2242.86%
AR is negative yoy while TSM is 369.81%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
76.32%
Some inventory rise while TSM is negative at -64843.00%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-291.18%
Both negative yoy AP, with TSM at -187.98%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-411.54%
Both reduce yoy usage, with TSM at -126.77%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
61.54%
Well above TSM's 22.01%. Michael Burry would worry about large intangible write-downs or revaluation gains overshadowing real performance.
-60.89%
Both yoy CFO lines are negative, with TSM at -21.26%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-5.88%
Both yoy lines negative, with TSM at -14.76%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
400.00%
Some acquisitions while TSM is negative at -72.30%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
95.37%
Purchases well above TSM's 28.18%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
50.53%
We have some liquidation growth while TSM is negative at -28.10%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-150.00%
Both yoy lines negative, with TSM at -49.32%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
302.14%
We have mild expansions while TSM is negative at -16.51%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
-167.70%
Both yoy lines negative, with TSM at -21170.72%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
100.00%
Issuance growth of 100.00% while TSM is zero at 0.00%. Bruce Berkowitz sees a mild dilution that must be justified by expansions or acquisitions vs. competitor’s stable share base.
9.52%
Buyback growth of 9.52% while TSM is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.